8-K - Caris Life Sciences, Inc. (0002019410) (Filer)
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Caris Life Sciences filed an 8-K with the SEC on Nov 4 (a notice of a material company event).
Directly affected
- CAI Caris Life Sciences+19.5% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Caris Life Sciences belongs to, so it often moves with news about it.
- NTRA Natera-0.5% 30d
Natera is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news.
- LH Labcorp Holdings+9.0% 30d
Labcorp Holdings is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news.
- DGX Quest Diagnostics+6.0% 30d
Quest Diagnostics is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news.
- GH Guardant Health+0.0% 9d
Guardant Health is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news.
- GRAL Grail+82.9% 8d
Grail is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CAI | +8.83% | -3.40% | base | after close | after close | after close | after close |
| XLV | -2.96% | -2.66% | base | after close | after close | after close | after close |
| NTRA | +11.54% | -3.13% | base | after close | after close | after close | after close |
| LH | +0.07% | -3.30% | base | after close | after close | after close | after close |
| DGX | -1.03% | -1.86% | base | after close | after close | after close | after close |
| GH | +9.92% | +1.31% | base | after close | after close | after close | after close |
| GRAL | +10.86% | -6.80% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-04 AccNo: 0002019410-26-000067 Size: 440 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Caris Life Sciences (CAI) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Caris Life Sciences (CAI) | three days earlier | -3.40% | final price |
| Caris Life Sciences (CAI) | five days earlier | +8.83% | final price |
| Quest Diagnostics (DGX) | three days earlier | -1.86% | final price |
| Quest Diagnostics (DGX) | five days earlier | -1.03% | final price |
| Guardant Health (GH) | three days earlier | +1.31% | final price |
| Guardant Health (GH) | five days earlier | +9.92% | final price |
| Grail (GRAL) | three days earlier | -6.80% | final price |
| Grail (GRAL) | five days earlier | +10.86% | final price |
| Labcorp Holdings (LH) | three days earlier | -3.30% | final price |
| Labcorp Holdings (LH) | five days earlier | +0.07% | final price |
| Natera (NTRA) | three days earlier | -3.13% | final price |
| Natera (NTRA) | five days earlier | +11.54% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.66% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -2.96% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Labcorp Holdings (LH) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $100,001 - $250,000 on 25 Aug 2026. That is 71 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. April McClain Delaney sold Labcorp Holdings (LH) (held by a dependent child), worth $1,001 - $15,000 on 7 Aug 2026. That is 89 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Rohit Khanna bought Quest Diagnostics (DGX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Jonathan Jackson bought Guardant Health (GH) (jointly held), worth $15,001 - $50,000 on 28 Sep 2026. That is 37 days before publication. Filed 19 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Caris Life Sciences, Inc. (0002019410) (Filer)”
Companies carried with this story
- CAI Caris Life Sciences
In “8-K - Caris Life Sciences, Inc. (0002019410) (Filer),” Caris Life Sciences (CAI) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> CAI
- XLV Select Sector Spdr Tr
Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - Caris Life Sciences, Inc. (0002019410) (Filer).” Reason on file: Health Care Select Sector SPDR holds the health sector that Caris Life Sciences belongs to, so it often moves with news about it
- NTRA Natera
For “8-K - Caris Life Sciences, Inc. (0002019410) (Filer),” Natera (NTRA) is linked, with no stored direction, medium confidence. Reason on file: Natera is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news
- LH Labcorp Holdings
Labcorp Holdings (LH) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - Caris Life Sciences, Inc. (0002019410) (Filer).” Reason on file: Labcorp Holdings is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news
- DGX Quest Diagnostics
Quest Diagnostics (DGX) is linked, with no stored direction, medium confidence in the 4 Nov 2026 story “8-K - Caris Life Sciences, Inc. (0002019410) (Filer).” Reason on file: Quest Diagnostics is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news
- GH Guardant Health
In “8-K - Caris Life Sciences, Inc. (0002019410) (Filer),” Guardant Health (GH) is linked, with no stored direction, medium confidence. Reason on file: Guardant Health is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news
- GRAL Grail
For “8-K - Caris Life Sciences, Inc. (0002019410) (Filer),” Grail (GRAL) is linked, with no stored direction, medium confidence. Reason on file: Grail is a peer of Caris Life Sciences in medical laboratories; rivals often move on the same news
How “8-K - Caris Life Sciences, Inc. (0002019410) (Filer)” reaches Caris Life Sciences (CAI)
Caris Life Sciences (CAI) is the company in “8-K - Caris Life Sciences, Inc. (0002019410) (Filer),” the 4 Nov 2026 this story story.
For Caris Life Sciences (CAI), the reason on file says SEC 8-K filing -> direct issuer disclosure -> CAI
A second company, Select Sector Spdr Tr (XLV), is listed for a different reason: Health Care Select Sector SPDR holds the health sector that Caris Life Sciences belongs to, so it often moves with news about it
Dates in the story, and the Caris Life Sciences (CAI) price range
CAI traded between 25.89 and 34.06 across 20 sessions. The latest close on file is 33.68. NTRA traded between 376.58 and 436.18 across 20 sessions. The latest close on file is 388.48.
How strong the case is around Caris Life Sciences (CAI)
46 out of 100
“8-K - Caris Life Sciences, Inc. (0002019410) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.